SCHEMBL2189010

SCHEMBL2189010

CC(C)C1=CC2=CCC3[C@@](C)(COCC4CO4)CCC[C@]3(C)[C@@H]2CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 3/20 0.66
▸ ALDH1A1 P00352 2/20 0.66
▸ LMNA P02545 2/20 0.66
▸ MAPK1 P28482 1/20 0.66
▸ HSD17B10 Q99714 3/20 0.54
▸ PDK1 Q15118 2/20 0.54
▸ PDK2 Q15119 2/20 0.54
▸ PDK3 Q15120 2/20 0.54
▸ PDK4 Q16654 2/20 0.54
▸ SLCO1B3 Q9NPD5 1/20 0.54
▸ SLCO1B1 Q9Y6L6 1/20 0.54
▸ GABRA1 P14867 1/20 0.54
▸ GABRB2 P47870 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12417300 1.00 ALOX15 (0.66) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL2189006 1.00 ALOX15 (0.66) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL8746013 0.90 ALOX15 (0.77) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL8746011 0.90 ALOX15 (0.77) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL11057181 0.82 ALOX15 (0.66) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL11057179 0.82 ALOX15 (0.66) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL8961448 0.82 ALOX15 (0.71) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL8961449 0.82 ALOX15 (0.71) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL19027534 0.81 ALOX15 (0.70) ALOX15ALDH1A1LMNAMAPK1HSD17B10
SCHEMBL10724643 0.80 HSD17B10 (0.67) ALOX15ALDH1A1LMNAMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104797674-B Modified polyphenol binder compositions and methods of making and using the same 佐治亚-太平洋化工品有限公司 2018-03-30 — — CN claimed
CN-117659377-A Unsaturated branched polyether, preparation method thereof and application of unsaturated branched polyether in preparation of phosphate water reducer 连云港苏博特新材料有限公司 2024-03-08 — — CN disclosed
CN-104797674-B Modified polyphenol binder compositions and methods of making and using the same 佐治亚-太平洋化工品有限公司 2018-03-30 — — CN disclosed
US-9029566-B2 Rosin derived epoxides and curing agents WASHINGTON STATE UNIVERSITY (US) 2015-05-12 — — US disclosed
US-20110172440-A1 ROSIN DERIVED EPOXIDES AND CURING AGENTS ZHANG JINWEN 2011-07-14 — — US disclosed
WO-2010033593-A2 ROSIN DERIVED EPOXIDES AND CURING AGENTS WASHINGTON STATE UNIVERSITY OIPA (US) 2010-03-25 — — WO disclosed
EP-0095175-B1 EPIHALOHYDRIN POLYMER CURE SYSTEMS Zeon Chemicals USA, Inc. (US) 1991-03-13 — — EP disclosed
EP-0106218-B1 BLOCK COPOLYMERS AND PROCESS FOR THEIR PREPARATION The B.F. GOODRICH Company (US) 1986-03-19 — — EP disclosed
US-4451618-A Block copolymers and process for their preparation THE B. F. GOODRICH COMPANY (US) 1984-05-29 — — US disclosed
EP-0106218-A1 Block copolymers and process for their preparation The B.F. GOODRICH Company (US) 1984-04-25 — — EP disclosed
US-RE31468-E POLYEPIHALOHYDRIN ENDCAPPED WITH HYDROXYALKYL ACRYLATE THE B. F. GOODRICH COMPANY (US) 1983-12-20 — — US disclosed
EP-0095175-A2 Epihalohydrin polymer cure systems Zeon Chemicals USA, Inc. (US) 1983-11-30 — — EP disclosed
US-4408013-A POLYETHER HAVING PENDANT UNSATURATION, POLACRYLATE OF POLYOL, PEROXIDE THE B. F. GOODRICH COMPANY (US) 1983-10-04 — — US disclosed
EP-0035029-A4 REACTIVE LIQUID POLYMERS. GOODRICH CO B F (US) 1982-01-26 — — EP disclosed
EP-0035029-A1 REACTIVE LIQUID POLYMERS The B.F. GOODRICH Company (US) 1981-09-09 — — EP disclosed
WO-1981000716-A1 REACTIVE LIQUID POLYMERS GOODRICH CO B F (US) 1981-03-19 — — WO disclosed
US-4256910-A AN EPIHALOHYDRIN POLYMER ENDCAPPED WITH AN HYDROXYALKYL ACRYLATE OR METHACRYLATE; TOUGHNESS AFTER CURING THE B. F. GOODRICH COMPANY (US) 1981-03-17 — — US disclosed
US-4251648-A CONTAINING AN UNSATURATED GLYCIDYL ETHER; AIRCRAFT AND AUTOMOTIVE USES THE B.F. GOODRICH COMPANY (US) 1981-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172440-A1 ROSIN DERIVED EPOXIDES AND CURING AGENTS EPHX1, EPHX2, RCOR1 ALOX15 102/4885ALDH1A1 70/4885LMNA 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback